News & Events

As opposed to conventional radiotherapy, FLASH radiotherapy delivers an ultra-high dose rate in a fraction of a second, destroying cancer cells without causing any collateral damage to healthy tissue. It gives great hope to cancer patients all over the world and shall revolutionize radiation therapy in the near future, making it safer, more precise and more efficient.

How will FLASH radiotherapy reshape the future of cancer care? And how will FLASHKNiFE be essential to clinical practice? Watch this video to know more!

PMB is proud to have partnered with the University Hospital of Lausanne (CHUV) for the first treatment of a human patient with FLASH-radiotherapy, in Switzerland. A 75-year-old patient with multiple skin tumors, was treated using the ORIATRON eRT6, a LINAC specifically engineered to safely accelerate electrons in a “FLASH” mode.